A two-stringed engagement project that supports ESTRO’s ambition to improve the outcome of cancer treatment, secured the ESTRO Annual Congress to Denmark.
The combination of an ambitious two-stringed engagement project, a strong national host group and an attractive host city were the deciding factors for The European Society for Radiotherapy and Oncology, ESTRO, when choosing Copenhagen for their 2022 Annual Meeting. The Congress will run over five days at the Bella Center Copenhagen and attract an estimated 6.000 participants.
The groundbreaking engagement project with the overarching theme ‘Improved cancer outcome through collaboration’ offers two areas of focus. Through projects and events, it aims to showcase and translate Danish experience and expertise to ESTRO members before, during and after the congress while also using the ESTRO congress as a catalyst to improve radiotherapy in Denmark and Europe.
ESTRO plays an integrated role in Danish radiotherapy. The national radiotherapy research center under the Danish Comprehensive Cancer Center, DCCC Radiotherapy, has been instrumental in putting together the engagement project and securing the winning bid.
With events, meetings and symposia all over Denmark leading up to the congress, it really will be a national effort and a testament to Danish collaboration. Copenhagen will be the focal point for the congress, while meetings leading up to the event will be held across the country.
The Danish bid for ESTRO comprised of two parts; an engagement project and a functional bid. The engagement project was co-created by DCCC, Wonderful Copenhagen and VisitAarhus. The functional bid was prepared by Wonderful Copenhagen, Bella Center Copenhagen and members of Meetingplace.